HomeLIMN • NASDAQ
add
Liminatus Pharma Inc
Previous close
$11.11
Day range
$12.00 - $23.38
Year range
$4.55 - $26.68
Market cap
528.36M USD
Avg Volume
256.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 255.00 | 3.24% |
Net income | -891.38K | -360,783.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -0.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.90K | -82.69% |
Total assets | 2.12M | -18.24% |
Total liabilities | 1.06K | -99.99% |
Total equity | -1.06K | — |
Shares outstanding | 26.01M | — |
Price to book | ∞ | — |
Return on assets | -72.04% | — |
Return on capital | -0.20% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -891.38K | -360,783.40% |
Cash from operations | 0.00 | — |
Cash from investing | 724.62K | 191.20% |
Cash from financing | -166.02K | -123.72% |
Net change in cash | -3.10K | -106.87% |
Free cash flow | -164.28K | -212.64% |
About
Founded
2020
Headquarters
